REZILIENT3 Trial: Major Positive Phase 3 Result in Exon 20 NSCLC
Aug 16, 2026
View online
REZILIENT3 Trial: Major Positive Phase 3 Result in Exon 20 NSCLC
Susan G. Komen Names Amber Guild as New President and CEO
Episode 18: Global Health Dialogues with Princess Dina and Dr Urvi Shah
5 Messages Shaping GI Oncology After ESMO GI 2026: Highlighted by Maria Maddalena Laterza
Lacy Hubbard: What Happens After You Screen Nearly Half a Million Women?
Angela Mastronuzzi: Book for Caring for the Child, Not Just the Tumor
10 Major Cancer Research Grants Offering $1M+
Community Oncology Global Congress 2026
EACR–Worldwide Cancer Research Collaboration Fellowship 2026
Pezcoller Foundation–EACR Translational Cancer Researcher Award 2027
The AORTICHORG 3rd Quarterly Webinar
International Society for Experimental Hematology (ISEH) 55th Annual Scientific Meeting
The Voice of Oncology
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
